Ameriprise Financial Inc. Has $1.91 Million Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Ameriprise Financial Inc. raised its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 31.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 90,782 shares of the company's stock after buying an additional 21,576 shares during the quarter. Ameriprise Financial Inc. owned about 0.22% of Phibro Animal Health worth $1,906,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of PAHC. Algert Global LLC grew its holdings in shares of Phibro Animal Health by 35.0% in the 4th quarter. Algert Global LLC now owns 96,272 shares of the company's stock valued at $2,022,000 after buying an additional 24,937 shares during the period. Parvin Asset Management LLC bought a new position in Phibro Animal Health during the fourth quarter worth about $282,000. AQR Capital Management LLC grew its stake in Phibro Animal Health by 27.8% in the fourth quarter. AQR Capital Management LLC now owns 327,418 shares of the company's stock valued at $6,876,000 after acquiring an additional 71,150 shares during the period. Northern Trust Corp grew its stake in Phibro Animal Health by 7.2% in the fourth quarter. Northern Trust Corp now owns 245,110 shares of the company's stock valued at $5,147,000 after acquiring an additional 16,421 shares during the period. Finally, Aquatic Capital Management LLC acquired a new stake in shares of Phibro Animal Health during the fourth quarter worth about $69,000. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Stock Down 1.4%

Shares of Phibro Animal Health stock traded down $0.35 during trading on Wednesday, reaching $23.97. The stock had a trading volume of 149,710 shares, compared to its average volume of 203,016. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. The company has a market capitalization of $971.60 million, a price-to-earnings ratio of 49.94, a P/E/G ratio of 0.45 and a beta of 0.62. The stock has a fifty day moving average price of $20.64 and a two-hundred day moving average price of $21.87. Phibro Animal Health Co. has a 52 week low of $16.16 and a 52 week high of $26.55.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Sell-side analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.00%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's payout ratio is 61.54%.

Analysts Set New Price Targets

PAHC has been the subject of several research analyst reports. Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research report on Monday, February 10th. Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, Morgan Stanley increased their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $20.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.